Mirelle (Ethinylestradiol, Gestodene | Lactose Monohydrate)

Ethinylestradiol / Gestodene, the active ingredient in Mirelle, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by suppressing ovulation, thickening cervical mucus, and inducing endometrial changes that reduce the likelihood of implantation.

GNH USA supplies Mirelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Mirelle, a combined oral contraceptive, is used to prevent pregnancy and manage menstrual‑related conditions.

Contraception: Prevents pregnancy by suppressing ovulation and altering cervical mucus. Menstrual cycle regulation: Helps establish regular, predictable menstrual bleeding. Acne management: Reduces androgen‑driven acne lesions in some women.

Mirelle may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Breast tenderness - Headache - Spotting between periods - Weight gain - Mood changes

Serious or Rare Side Effects: - Deep vein thrombosis or pulmonary embolism - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension - Liver tumor or cholestatic jaundice - Anaphylactic reaction

Before prescribing Mirelle, clinicians should consider several safety precautions.

Contraindicated in pregnancy: product is classified as pregnancy category X and must not be used. Smoking over age 35: increased risk of thromboembolic events; avoid use. Cardiovascular disease: assess risk of hypertension, stroke, or myocardial infarction. History of thromboembolism: avoid due to elevated clotting risk. Liver disease: use with caution as metabolism may be impaired. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Mirelle can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): reduce contraceptive effectiveness. - Rifampicin and other potent antibiotics: may lower hormone levels. - Protease inhibitors (e.g., ritonavir): can alter hormone metabolism.

Moderate Interactions (Monitor Closely): - Antifungal agents such as ketoconazole: may increase hormone concentrations. - St. John’s wort: may decrease effectiveness. - Certain antihypertensives (e.g., ACE inhibitors): monitor blood pressure. - Diuretics: may affect electrolyte balance.